Effectiveness of Cisplatin in P16+ Oropharyngeal Cancer According to Relative Risk for Cancer Events: Ancillary Analysis of RTOG 1016

H.C. Liu, R. Morse,T.J. Nelson,C.W. Williamson,L. Vitzthum,K. Zakeri, G. Henderson,C.A. Thompson, J. Zou,M. Gillison,L.K. Mell

International journal of radiation oncology, biology, physics（2023）

引用 0|浏览14

暂无评分

摘要

The effectiveness of cisplatin in p16+ OPSCC increased with higher omega score but not with standard risk group. Relative risk for cancer events should be taken into account when designing deintensification strategies.

查看译文

关键词

oropharyngeal cancer,cisplatin,cancer events

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要